The approach study: a randomized, double-blind, placebo-controlled, phase 3 study of volanesorsen administered subcutaneously to patients with familial chylomicronemia syndrome (FCS)

Daniel Gaudet; Andres Digenio; Vickie Alexander; Marcello Arca; Alan Jones; Erik Stroes; Jean Bergeron; Ferdando Civeira; Linda Hemphill; Dirk Blom; Joann Flaim; Steven Hughes; Richard Geary; Sotirios Tsimikas; Joseph Witztum; Eric Bruckert

doi:10.1016/j.atherosclerosis.2017.06.059

Conference Papers Year : 2017

The approach study: a randomized, double-blind, placebo-controlled, phase 3 study of volanesorsen administered subcutaneously to patients with familial chylomicronemia syndrome (FCS)

, , , , , , , , , , , , , , , (1)

1

Daniel Gaudet

Function : Author

Andres Digenio

Function : Author

Vickie Alexander

Function : Author

Marcello Arca

Function : Author

Alan Jones

Function : Author

Erik Stroes

Function : Author

Jean Bergeron

Function : Author

Ferdando Civeira

Function : Author

Linda Hemphill

Function : Author

Dirk Blom

Function : Author

Joann Flaim

Function : Author

Steven Hughes

Function : Author

Richard Geary

Function : Author

Sotirios Tsimikas

Function : Author

Joseph Witztum

Function : Author

Eric Bruckert

Function : Author

Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases

Domains

Life Sciences [q-bio]

Maryse Guerin : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03969700

Submitted on : Thursday, February 2, 2023-2:14:26 PM

Last modification on : Saturday, October 7, 2023-9:36:24 PM

Dates and versions

hal-03969700 , version 1 (02-02-2023)

Identifiers

HAL Id : hal-03969700 , version 1
DOI : 10.1016/j.atherosclerosis.2017.06.059

Cite

Daniel Gaudet, Andres Digenio, Vickie Alexander, Marcello Arca, Alan Jones, et al.. The approach study: a randomized, double-blind, placebo-controlled, phase 3 study of volanesorsen administered subcutaneously to patients with familial chylomicronemia syndrome (FCS). 85th Congress of the European-Atherosclerosis-Society (EAS), Apr 2017, Prague, Czech Republic. pp.e10, ⟨10.1016/j.atherosclerosis.2017.06.059⟩. ⟨hal-03969700⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

ICAN SORBONNE-UNIVERSITE SU-MEDECINE IHU_ICAN

4 View

0 Download

The approach study: a randomized, double-blind, placebo-controlled, phase 3 study of volanesorsen administered subcutaneously to patients with familial chylomicronemia syndrome (FCS)

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share